A dynamic COVID-19 immune signature includes associations with poor prognosis
Open accessPublished version of a preprint
Abstract
Improved understanding and management of COVID-19, a potentially life-threatening disease, could greatly reduce the threat posed by its etiologic agent, SARS-CoV-2. Toward this end, we have identified a core peripheral blood immune signature across 63 hospital-treated patients with COVID-19 who were otherwise highly heterogeneous. The signature includes discrete changes in B and myelomonocytic cell composition, profoundly altered T cell phenotypes, selective cytokine/chemokine upregulation and SARS-CoV-2-specific antibodies. Some signature traits identify links with other settings of immunoprotection and immunopathology; others, including basophil and plasmacytoid dendritic cell depletion, correlate strongly with disease severity; while a third set of traits, including a triad of IP-10, interleukin-10 and interleukin-6, anticipate subsequent clinical progression. Hence, contingent upon independent validation in other COVID-19 cohorts, individual traits within this signature may collectively and individually guide treatment options; offer insights into COVID-19 pathogenesis; and aid early, risk-based patient stratification that is particularly beneficial in phasic diseases such as COVID-19.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Certain cytokines such as IL-1β and IL-6 have clearly emerged as key to promoting inflammaging.
“Certain cytokines, such as IL-1β and IL-6, have clearly emerged as key to promoting inflammaging.83,229–232”
From Inflammation and aging: signaling pathways and intervention therapies (2023) · cites this paper as [232]
The ‘Robust B cell responses to SARS-CoV-2’ section reports elevated IL-6 in COVID-19 patients, not a role for IL-6 or IL-1β in promoting inflammaging. Searches for ‘inflammaging’ and for IL-1β with age-related inflammation found no passage addressing that claim. No page number was available in the indexed passages. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · see citing works
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246 · see citing works
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · see citing works
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969 · see citing works
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477 · see citing works
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
Horby, P., Lim, W. S., Emberson, J., Mafham, M., Bell, J., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., et al. (2020) · doi:10.1101/2020.06.22.20137273 · Cited by 11,475 · see citing works
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664 · see citing works
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661 · see citing works
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Zou, L., Ruan, F., Huang, M.-X., Liang, L.-J., Huang, H., Hong, Z.-S., Yu, J.-X., Kang, M., Song, Y.-C., Xia, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001737 · Cited by 4,590 · see citing works
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405 · see citing works
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222 · see citing works
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595 · see citing works
Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ · doi:10.1136/bmj.m1985 · Cited by 3,481 · see citing works
Cell entry mechanisms of SARS-CoV-2
Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A., & Li, F. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003138117 · Cited by 3,142 · see citing works
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Merad, M., & Martin, J. C. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0331-4 · Cited by 2,472 · see citing works
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J., Wang, F., Li, D., Yang, M., Xing, L., et al. (2020) · JAMA · doi:10.1001/jama.2020.4783 · Cited by 2,278 · see citing works
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Giamarellos-Bourboulis, E. J., Netea, M. G., Rovina, N., Akinosoglou, K., Antoniadou, A., Antonakos, N., Damoraki, G., Gkavogianni, T., Adami, M.-E., Katsaounou, P., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.009 · Cited by 2,045 · see citing works
Genomewide Association Study of Severe Covid-19 with Respiratory Failure
The Severe Covid-19 GWAS Group (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2020283 · Cited by 1,986 · see citing works
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Duan, K., Liu, B., Li, C., Zhang, H., Yu, T., Qu, J., Zhou, M., Chen, L., Meng, S., Hu, Y., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004168117 · Cited by 1,962 · see citing works
Cytokine release syndrome in severe COVID-19
Moore, J. B., & June, C. H. (2020) · Science · doi:10.1126/science.abb8925 · Cited by 1,912 · see citing works
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788 · see citing works
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Zheng, M., Gao, Y., Wang, G., Song, G., Liu, S., Sun, D., Xu, Y., & Tian, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0402-2 · Cited by 1,768 · see citing works
Liu, J., Li, S., Liu, J., Liang, B., Wang, X., Wang, H., Li, W., Tong, Q., Yi, J., Zhao, L., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102763 · Cited by 1,705 · see citing works
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Ju, B., Zhang, Q., Ge, J., Wang, R., Sun, J., Ge, X., Yu, J., Shan, S., Zhou, B., Song, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2380-z · Cited by 1,667 · cited 1× · see citing works
“Thus, we employed eight multiparameter flow cytometry panels (P1–P8), measuring: (1) broad lymphocyte composition; (2) effector/memory T cell status; (3) γδ T cell status; (4) B cells; (5) cell cycling; (6) leukocyte counts; (7) lymphocyte activation and exhaustion; and (8) innate immune cells.”
MethodImmunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623 · see citing works
Mathew, D., Giles, J. R., Baxter, A. E., Oldridge, D. A., Greenplate, A. R., Wu, J. E., Alanio, C., Kuri-Cervantes, L., Pampena, M. B., D’Andrea, K., et al. (2020) · Science · doi:10.1126/science.abc8511 · Cited by 1,509 · see citing works
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Wilk, A. J., Rustagi, A., Zhao, N. Q., Roque, J., Martínez-Colón, G. J., McKechnie, J. L., Ivison, G. T., Ranganath, T., Vergara, R., Hollis, T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0944-y · Cited by 1,493 · see citing works
Targeting potential drivers of COVID-19: Neutrophil extracellular traps
Barnes, B. J., Adrover, J. M., Baxter-Stoltzfus, A., Borczuk, A., Cools-Lartigue, J., Crawford, J. M., Daßler-Plenker, J., Guerci, P., Huynh, C., Knight, J. S., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200652 · Cited by 1,486 · see citing works
Carsana, L., Sonzogni, A., Nasr, A., Rossi, R. S., Pellegrinelli, A., Zerbi, P., Rech, R., Colombo, R., Antinori, S., Corbellino, M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30434-5 · Cited by 1,402 · see citing works
Severe Herpesvirus Infections in an Adolescent without Natural Killer Cells
Biron, C. A., Byron, K. S., & Sullivan, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906293202605 · Cited by 1,280 · see citing works
SARS-CoV-2 and viral sepsis: observations and hypotheses
Li, H., Liu, L., Zhang, D., Xu, J., Dai, H., Tang, N., Su, X., & Cao, B. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30920-x · Cited by 1,176 · see citing works
Immunological mechanisms of vaccination
Pulendran, B., & Ahmed, R. (2011) · Nature Immunology · doi:10.1038/ni.2039 · Cited by 1,093 · see citing works
Another Decade, Another Coronavirus
Perlman, S. M. (2020) · New England Journal of Medicine · doi:10.1056/nejme2001126 · Cited by 1,066 · see citing works
Complement System Part II: Role in Immunity
Merle, N. S., Noé, R., Halbwachs‐Mecarelli, L., Frémeaux‐Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00257 · Cited by 1,054 · see citing works
Weiskopf, D., Schmitz, K. S., Raadsen, M. P., Grifoni, A., Okba, N. M. A., Endeman, H., van den Akker, J. P. C., Molenkamp, R., Koopmans, M. P. G., van Gorp, E. C. M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd2071 · Cited by 907 · see citing works
Comprehensive mapping of immune perturbations associated with severe COVID-19
Kuri-Cervantes, L., Pampena, M. B., Meng, W., Rosenfeld, A. M., Ittner, C. A. G., Weisman, A. R., Agyekum, R. S., Mathew, D., Baxter, A. E., Vella, L. A., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd7114 · Cited by 723 · see citing works
An interferon‐γ‐related cytokine storm in SARS patients
Huang, K., Su, I., Theron, M., Wu, Y., Lai, S., Liu, C., & Lei, H. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20255 · Cited by 679 · see citing works
Self-citationCOVID-19 pneumonia: ARDS or not?
Gattinoni, L., Chiumello, D., & Rossi, S. (2020) · Critical Care · doi:10.1186/s13054-020-02880-z · Cited by 675 · see citing works
Postmortem Examination of Patients With COVID-19
Schaller, T., Hirschbühl, K., Burkhardt, K., Braun, G., Trepel, M., Märkl, B., & Claus, R. (2020) · JAMA · doi:10.1001/jama.2020.8907 · Cited by 557 · see citing works
Host Factors in Coronavirus Replication
de Wilde, A. H., Snijder, E. J., Kikkert, M., & van Hemert, M. J. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_25 · Cited by 542 · see citing works
The impact of ethnicity on clinical outcomes in COVID-19: A systematic review
Pan, D., Sze, S., Minhas, J. S., Bangash, M. N., Pareek, N., Divall, P., Williams, C., Oggioni, M. R., Squire, I. B., Nellums, L. B., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100404 · Cited by 520 · see citing works
Tang, F., Quan, Y., Xin, Z.-T., Wrammert, J., Ma, M.-J., Lv, H., Wang, T.-B., Yang, H., Richardus, J. H., Liu, W., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903490 · Cited by 496 · see citing works
Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
Ng, O.-W., Chia, A., Tan, A. T., Jadi, R. S., Leong, H. N., Bertoletti, A., & Tan, Y.-J. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.02.063 · Cited by 436 · see citing works
The Compensatory Anti-inflammatory Response Syndrome (CARS) in Critically Ill Patients
Ward, N. S., Casserly, B. P., & Ayala, A. (2008) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2008.06.010 · Cited by 407 · see citing works
Chen, R., Sang, L., Jiang, M., Yang, Z., Jia, N., Fu, W., Xie, J., Guan, W., Liang, W., Ni, Z., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.003 · Cited by 376 · see citing works
Nizzoli, G., Krietsch, J., Weick, A., Steinfelder, S., Facciotti, F., Gruarin, P., Bianco, A., Steckel, B., Moro, M., Crosti, M., et al. (2013) · Blood · doi:10.1182/blood-2013-04-495424 · Cited by 328 · see citing works
The role of leukocytes in thrombosis
Swystun, L. L., & Liaw, P. C. (2016) · Blood · doi:10.1182/blood-2016-05-718114 · Cited by 301 · see citing works
AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies
Meyer, S., Woodward, M., Hertel, C. B., Vlaicu, P., Haque, Y., Kärner, J., Macagno, A., Onuoha, S. C., Fishman, D., Peterson, H., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.024 · Cited by 293 · see citing works
Self-citationA Dynamic Immune Response Shapes COVID-19 Progression
Ong, E. Z., Chan, Y. F. Z., Leong, W. Y., Lee, N. M. Y., Kalimuddin, S., Mohideen, S. M. H., Chan, K. S., Tan, A. T., Bertoletti, A., Ooi, E. E., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.03.021 · Cited by 290 · see citing works
Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19Preprint
Sekine, T., Perez‐Potti, A., Rivera‐Ballesteros, O., Strålin, K., Gorin, J., Olsson, A., Llewellyn‐Lacey, S., Kamal, H., Bogdanović, G., Muschiol, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.29.174888 · Cited by 272 · see citing works
Kwissa, M., Nakaya, H. I., Onlamoon, N., Wrammert, J., Villinger, F. J., Perng, G., Yoksan, S., Pattanapanyasat, K., Chokephaibulkit, K., Ahmed, R., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.06.001 · Cited by 257 · see citing works
Immunosenescence: influenza vaccination and the elderly
Haq, K., & McElhaney, J. E. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.03.008 · Cited by 256 · see citing works
Potent human neutralizing antibodies elicited by SARS-CoV-2 infectionPreprint
Ju, B., Zhang, Q., Ge, X., et al. (2020) · bioRxiv · doi:10.1101/2020.03.21.990770 · Cited by 256 · see citing works
Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis
Wilson, J. G., Simpson, L. J., Ferreira, A.-M., Rustagi, A., Roque, J., Asuni, A., Ranganath, T., Grant, P., Subramanian, A. K., Rosenberg‐Hasson, Y., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.140289 · Cited by 250 · see citing works
Singh, A. K., Gupta, R., & Misra, A. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.03.016 · Cited by 243 · see citing works
Immunological memory: lessons from the past and a look to the future
Farber, D. L., Netea, M. G., Radbruch, A., Rajewsky, K., & Zinkernagel, R. M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.13 · Cited by 200 · see citing works
Yang, R., Gui, X., & Xiong, Y. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.10182 · Cited by 199 · see citing works
Guo, C., Li, B., Ma, H., Wang, X., Cai, P., Yu, Q., Zhu, L., Jin, L., Jiang, C., Fang, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17834-w · Cited by 199 · see citing works
Luchsinger, L. L., Ransegnola, B. P., Jin, D. K., Muecksch, F., Weisblum, Y., Bao, W., George, P. J., Rodriguez, M., Tricoche, N., Schmidt, F., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02005-20 · Cited by 187 · see citing works
Animal coronaviruses : what can they teach us about the severe acute respiratory syndrome?
Saif, L. J. (2004) · Scientific and Technical Review (World Organisation for Animal Health) · doi:10.20506/rst.23.2.1513 · Cited by 173 · see citing works
Dunning, J. W., Blankley, S., Hoang, L. T., Cox, M. J., Graham, C. M., James, P. L., Bloom, C. I., Chaussabel, D., Banchereau, J., Brett, S. J., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0111-5 · Cited by 156 · see citing works
Self-citationSobolev, O., Binda, E., O’Farrell, S., Lorenc, A., Pradines, J., Huang, Y., Duffner, J. L., Schulz, R., Cason, J. W., Zambon, M. C. F. A., et al. (2016) · Nature Immunology · doi:10.1038/ni.3328 · Cited by 149 · see citing works
Self-citationShin, H., Kim, Y., Kim, G., Lee, J. Y., Jeong, I., Joh, J.-S., Kim, H., Chang, E., Sim, S. Y., Park, J.-S., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy595 · Cited by 148 · see citing works
Lafarge, X., Merville, P., Cazin, M., Bergé, F., Potaux, L., Moreau, J., & Déchanet‐Merville, J. (2001) · The Journal of Infectious Diseases · doi:10.1086/322843 · Cited by 145 · see citing works
Forty years with coronaviruses
Weiss, S. R. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20200537 · Cited by 143 · see citing works
Activation-Associated Accelerated Apoptosis of Memory B Cells in Critically Ill Patients With Sepsis
Shankar‐Hari, M., Fear, D. J., Lavender, P., Mare, T. A., Beale, R. J., Swanson, C. M., Singer, M., & Spencer, J. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002380 · Cited by 129 · see citing works
Self-citationMathew, D., Giles, J. R., Baxter, A. E., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.20.106401 · Cited by 115 · see citing works
Pickering, S., Betancor, G., Galão, R. P., Merrick, B., Signell, A. W., Wilson, H., Ik, M. T. K., Seow, J., Graham, C., Acors, S., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008817 · Cited by 107 · see citing works
Self-citationDiagnostic importance of relative lymphopenia as a marker of swine influenza (H1N1) in adults.
Cunha, B. A., Pherez, F. M., & Schoch, P. (2009) · Clinical Infectious Diseases · doi:10.1086/644496 · Cited by 104 · see citing works
Formation of the outer dense fibers during spermiogenesis in the rat
Irons, M. J., & Clermont, Y. (1982) · The Anatomical Record · doi:10.1002/ar.1092020405 · Cited by 102 · see citing works
Animal coronavirus vaccines: lessons for SARS.
Saif, L. J. (2004) · PubMed · Cited by 87 · see citing works
Basophil-derived tumor necrosis factor can enhance survival in a sepsis model in mice
Piliponsky, A. M., Shubin, N. J., Lahiri, A. K., Truong, P., Clauson, M., Niino, K., Tsuha, A., Nedospasov, S. A., Karasuyama, H., Reber, L. L., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0288-7 · Cited by 78 · see citing works
A single-cell atlas of the peripheral immune response to severe COVID-19Preprint
Wilk, A. J., Rustagi, A., Zhao, N. Q., et al. (2020) · medRxiv · doi:10.1101/2020.04.17.20069930 · Cited by 75 · see citing works
The embryonic origin of endocrine cells of the gastrointestinal tract
Andrew, A., Kramer, B., & Rawdon, B. B. (1982) · General and Comparative Endocrinology · doi:10.1016/0016-6480(82)90228-3 · Cited by 73 · see citing works
Lakshmikanth, T., Olin, A., Chen, Y., Mikeš, J., Fredlund, E., Remberger, M., Omazic, B., & Brodin, P. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.021 · Cited by 67 · see citing works
Gyo, K., & Yanagihara, N. (1982) · Auris Nasus Larynx · doi:10.1016/s0385-8146(82)80001-1 · Cited by 65 · see citing works
Agrati, C., D’Offizi, G., Narciso, P., Abrignani, S., Ippolito, G., Colizzi, V., & Poccia, F. (2001) · PubMed Central · Cited by 60 · see citing works
Dendritic Cells in Sepsis: Pathological Alterations and Therapeutic Implications
Wu, D., Li, T., & Ji, X. (2017) · Journal of Immunology Research · doi:10.1155/2017/3591248 · Cited by 56 · see citing works
Agrati, C., D’Offizi, G., Narciso, P., Abrignani, S., Ippolito, G., Colizzi, V., & Poccia, F. (2001) · Molecular Medicine · doi:10.1007/bf03401834 · Cited by 56 · see citing works
Mantón, K. G., & Stallard, E. (1981) · Demography · doi:10.2307/2061094 · Cited by 52 · see citing works
da Mota, N. V. F., Brunialti, M. K. C., Santos, S. S., Machado, F. R., de Assunção, M. S. C., Azevedo, L. C. P., & Salomão, R. (2017) · Shock · doi:10.1097/shk.0000000000001078 · Cited by 52 · see citing works
Immunologic perturbations in severe COVID-19/SARS-CoV-2 infectionPreprint
Kuri-Cervantes, L., Pampena, M. B., Meng, W., Rosenfeld, A. M., Ittner, C. A. G., Weisman, A. R., Agyekum, R. S., Mathew, D., Baxter, A. E., Vella, L. A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.18.101717 · Cited by 50 · see citing works
Mast Cells and Basophils: A Potential Link in Promoting Angiogenesis during Allergic Inflammation
Enrico Crivellato, B., Travan, L., & Ribatti, D. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000235998 · Cited by 49 · see citing works
Barbiturate and hypnosedative withdrawal by a multiple oral phenobarbital loading dose technique
Robinson, G., Sellers, E. M., & Janecek, E. (1981) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1981.129 · Cited by 43 · see citing works
Abeler‐Dörner, L., Laing, A. G., Lorenc, A., Ushakov, D. S., Clare, S., Speak, A. O., Correa, M. A. D., White, J. K., Ramírez‐Solis, R., Saran, N., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0549-0 · Cited by 42 · see citing works
Self-citationDiscrimination of agonist and antagonist forms of CXCL10 in biological samples
Casrouge, A., Bisiaux, A., Stephen, L. F., Schmolz, M., Mapes, J. P., Pfister, C., Pol, S., Mallet, V. O., & Albert, M. L. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04488.x · Cited by 40 · see citing works
Calculated decisions: COVID-19 calculators during extreme resource-limited situations.
Steinberg, E., Balakrishna, A., Habboushe, J. P., Shawl, A., & Lee, J. (2020) · PubMed · Cited by 35 · see citing works
[A case of hypopotassemic myopathy].
Sepe, O., Valiani, R., Am, F., Mandarini, A., & Verdoliva, A. (1981) · PubMed · Cited by 28 · see citing works
Pickering, S., Betancor, G., Galão, R. P., et al. (2020) · medRxiv · doi:10.1101/2020.06.02.20120345 · Cited by 27 · see citing works
Gomersall, C. D., Kargel, M. J., & Lapinsky, S. E. (2004) · Critical Care · doi:10.1186/cc2452 · Cited by 26 · see citing works
Goodbye SIRS? Innate, trained and adaptive immunity and pathogenesis of organ dysfunction
Ghnewa, Y. G., Fish, M., Jennings, A. R., Carter, M. J., & Shankar‐Hari, M. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00683-2 · Cited by 20 · see citing works
Self-citationAntigen‐specific CD8 T cells in cell cycle circulate in the blood after vaccination
Simonetti, S., Natalini, A., Folgori, A., Capone, S., Nicosia, A., Santoni, A., & Rosa, F. D. (2018) · Scandinavian Journal of Immunology · doi:10.1111/sji.12735 · Cited by 18 · see citing works
Mendes-Aguiar, C. D. O., Gomes-Silva, A., Nunes, E., Jr., Pereira-Carvalho, R., Nogueira, R., Oliveira-Neto, M., Bertho, Á. L., & Da‐Cruz, A. M. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03970.x · Cited by 14 · see citing works
Tracking immunodynamics by identification of S-G2/M-phase T cells in human peripheral blood
Muñoz‐Ruiz, M., Pujol‐Autonell, I., Rhys, H. I., Long, H. M., Greco, M., Peakman, M., Tree, T. I. M., Hayday, A., & Rosa, F. D. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102466 · Cited by 13 · see citing works
Self-citationCharacterization of biological variation of peripheral blood immune cytome in an Indian cohort
Kanodia, P., Kaur, G., Coshic, P., Chatterjee, K., Neeman, T. M., George, A., Rath, S., Bal, V., & Prabhu, S. B. (2019) · Scientific Reports · doi:10.1038/s41598-019-51294-7 · Cited by 9 · see citing works
Abeler‐Dörner, L., Laing, A. G., Lorenc, A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/688010 · Cited by 5 · see citing works
Self-citationCancellation of coherent line-frequency noise in evoked potential recordings.
Jj, A., Antonich, F. J., & Halbach, R. E. (1980) · PubMed · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.
Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., et al. (2021) · Science · doi:10.1126/science.abf4063 · Cited by 2,656 · see citing works
Adaptive immunity to SARS-CoV-2 and COVID-19
Sette, A., & Crotty, S. (2021) · Cell · doi:10.1016/j.cell.2021.01.007 · Cited by 1,860 · see citing works
Rydyznski Moderbacher, C., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., Belanger, S., Abbott, R. K., Kim, C., Choi, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.038 · Cited by 1,790 · see citing works
“…(IP-10), IL-8, and IL-6 were elevated in acute COVID-19 (p < 0.0001, p < 0.05, p < 0.001; Figures S5A–S5C) and correlated with disease severity (Figure 5A), consistent with large cohort studies of plasma cytokines (Chen et al., 2020; Laing et al., 2020; Mathew et al., 2020; Yang et al., 2020).”
InfluentialKarki, R., Sharma, B. R., Tuladhar, S., Williams, E. P., Zalduondo, L., Samir, P., Zheng, M., Sundaram, B., Banoth, B., Malireddi, R. K. S., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.025 · Cited by 1,734 · see citing works
Mathew, D., Giles, J. R., Baxter, A. E., Oldridge, D. A., Greenplate, A. R., Wu, J. E., Alanio, C., Kuri-Cervantes, L., Pampena, M. B., D’Andrea, K., et al. (2020) · Science · doi:10.1126/science.abc8511 · Cited by 1,509 · see citing works
Inflammation and aging: signaling pathways and intervention therapies
Li, X., Li, C., Zhang, W., Wang, Y., Qian, P., & Huang, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01502-8 · Cited by 1,443 · see citing works
Seow, J., Graham, C., Merrick, B., Acors, S., Pickering, S., Steel, K. J. A., Hemmings, O., O’Byrne, A., Kouphou, N., Galao, R. P., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00813-8 · Cited by 1,419 · see citing works
Self-citationYeoh, Y. K., Zuo, T., Lui, G. C.-Y., Zhang, F., Liu, Q., Li, A. Y. L., Chung, A. C., Cheung, C. P., Tso, E. Y. K., Fung, K. S., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-323020 · Cited by 1,320 · see citing works
The T cell immune response against SARS-CoV-2
Moss, P. A. H. (2022) · Nature Immunology · doi:10.1038/s41590-021-01122-w · Cited by 1,205 · see citing works
Diverse functional autoantibodies in patients with COVID-19
Wang, E. Y., Mao, T., Klein, J., Dai, Y., Huck, J. D., Jaycox, J. R., Liu, F., Zhou, T., Israelow, B., Wong, P., et al. (2021) · Nature · doi:10.1038/s41586-021-03631-y · Cited by 999 · see citing works
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
Simonovich, V., Pratx, L. D. B., Scibona, P., Beruto, V., Vallone, M. G., Vázquez, C., Savoy, N., Giunta, D. H., Pérez, L. G., Sanchez, M. D. L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2031304 · Cited by 907 · see citing works
T cell responses in patients with COVID-19
Chen, Z., & John Wherry, E. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0402-6 · Cited by 797 · see citing works
COVID-19 and the human innate immune system
Schultze, J. L., & Aschenbrenner, A. C. (2021) · Cell · doi:10.1016/j.cell.2021.02.029 · Cited by 714 · see citing works
The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Domingo, P., Mur, I., Mateo, G. M., Gutierrez, M. D. M., Pomar, V., de Benito, N., Corbacho, N., Herrera, S., Millan, L., et al. (2021) · JAMA · doi:10.1001/jama.2021.11330 · Cited by 678 · see citing works
Self-citationAttenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
Shuai, H., Chan, J. F.-W., Hu, B., Chai, Y., Yuen, T. T.-T., Yin, F., Huang, X., Yoon, C., Hu, J., Liu, H., et al. (2022) · Nature · doi:10.1038/s41586-022-04442-5 · Cited by 637 · see citing works
Self-citationInnate immunity: the first line of defense against SARS-CoV-2
Diamond, M., & Kanneganti, T. (2022) · Nature Immunology · doi:10.1038/s41590-021-01091-0 · Cited by 612 · see citing works
Monin, L., Laing, A. G., Muñoz‐Ruiz, M., McKenzie, D. R., del Barrio, I. D. M., Alaguthurai, T., Domingo‐Vila, C., Hayday, T. S., Graham, C., Seow, J., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00213-8 · Cited by 612 · see citing works
Self-citationThe signal pathways and treatment of cytokine storm in COVID-19
Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., & Zhou, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00679-0 · Cited by 599 · see citing works
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
Poland, G., Ovsyannikova, I., & Kennedy, R. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32137-1 · Cited by 540 · see citing works
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531 · see citing works
Self-citationCD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
Bange, E. M., Han, N. A., Wileyto, P., Kim, J. Y., Gouma, S., Robinson, J., Greenplate, A. R., Hwee, M. A., Porterfield, F., Owoyemi, O., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01386-7 · Cited by 519 · see citing works
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
Osuchowski, M., Winkler, M., Skirecki, T., Cajander, S., Shankar-Hari, M., Lachmann, G., Monneret, G., Venet, F., Bauer, M., Brunkhorst, F., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00218-6 · Cited by 396 · see citing works
Self-citationPathophysiology of COVID-19-associated acute kidney injury
Legrand, M. M., Bell, S., Forni, L. G., Joannidis, M., Koyner, J. L., Liu, K. D., & Cantaluppi, V. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00452-0 · Cited by 508 · see citing works
The first 12 months of COVID-19: a timeline of immunological insights
Carvalho, T., Krammer, F., & Iwasaki, A. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00522-1 · Cited by 448 · see citing works
Carter, M. J., Fish, M., Jennings, A., Doores, K. J., Wellman, P., Seow, J., Acors, S., Graham, C., Timms, E., Kenny, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1054-6 · Cited by 419 · see citing works
Self-citationSzabo, P. A., Dogra, P., Gray, J. I., Wells, S. B., Connors, T. J., Weisberg, S. P., Krupska, I., Matsumoto, R., Poon, M. M. L., Idzikowski, E., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.03.005 · Cited by 371 · see citing works
Antibody response to SARS-CoV-2 infection in humans: A systematic review
Post, N., Eddy, D., Huntley, C., van Schalkwyk, M. C. I., Shrotri, M., Leeman, D., Rigby, S., Williams, S., Bermingham, W., Kellam, P., et al. (2020) · medRxiv · doi:10.1371/journal.pone.0244126 · Cited by 341 · see citing works
The spatial landscape of lung pathology during COVID-19 progression
Rendeiro, A. F., Ravichandran, H., Bram, Y., Chandar, V., Kim, J., Meydan, C., Park, J., Foox, J., HETHER, T. D., Warren, S. E., et al. (2021) · Nature · doi:10.1038/s41586-021-03475-6 · Cited by 353 · see citing works
T cell response to SARS-CoV-2 infection in humans: A systematic review
Shrotri, M., van Schalkwyk, M. C. I., Post, N., Eddy, D., Huntley, C., Leeman, D., Rigby, S., Williams, S., Bermingham, W., Kellam, P., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245532 · Cited by 126 · see citing works
An immune-based biomarker signature is associated with mortality in COVID-19 patients
Abers, M. S., Delmonte, O. M., Ricotta, E., Fintzi, J., Fink, D. L., de Jesus, A. A., Zarember, K. A., Alehashemi, S., Oikonomou, V., Desai, J. V., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.144455 · Cited by 335 · see citing works
Early Immune Pathology and Persistent Dysregulation Characterise Severe COVID-19
Bergamaschi, L., Mescia, F., Turner, L., Hanson, A., Kotagiri, P., Dunmore, B. J., Ruffieux, H., Sa, A. D., Huhn, O., Morgan, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2021.05.010 · Cited by 323 · see citing works
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
Le Bert, N., Clapham, H. E., Tan, A. T., Chia, W. N., Tham, C. Y. L., Lim, J. M., Kunasegaran, K., Tan, L. W. L., Dutertre, C.-A., Shankar, N., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20202617 · Cited by 330 · see citing works
Inflammasome activation at the crux of severe COVID-19
Vora, S. M., Lieberman, J., & Wu, H. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00588-x · Cited by 323 · see citing works
Immune and inflammatory mechanisms in hypertension
Guzik, T. J., Nosalski, R., Maffia, P., & Drummond, G. R. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00964-1 · Cited by 346 · see citing works
A guide to immunotherapy for COVID-19
van de Veerdonk, F. L., Giamarellos‐Bourboulis, E. J., Pickkers, P., Derde, L. P. G., Leavis, H. L., van Crevel, R., Engel, J. J., Wiersinga, W. J., Vlaar, A. P. J., Shankar‐Hari, M., et al. (2022) · Nature Medicine · doi:10.1038/s41591-021-01643-9 · Cited by 319 · see citing works
Self-citationSenolytics reduce coronavirus-related mortality in old mice
Camell, C. D., Yousefzadeh, M. J., Zhu, Y., Prata, L. G. P. L., Huggins, M. A., Pierson, M., Zhang, L., O’Kelly, R. D., Pirtskhalava, T., Xun, P., et al. (2021) · Science · doi:10.1126/science.abe4832 · Cited by 320 · see citing works
Peluso, M. J., Lu, S., Tang, A. F., Durstenfeld, M. S., Ho, H.-E., Goldberg, S. A., Forman, C. A., Munter, S. E., Hoh, R., Tai, V., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab490 · Cited by 318 · see citing works
Ventilator-associated pneumonia in critically ill patients with COVID-19
Maes, M., Higginson, E. E., Pereira-Dias, J., Curran, M. D., Parmar, S., Khokhar, F., Cuchet, D., Lux, J., Sharma-Hajela, S., Ravenhill, B., et al. (2021) · Critical Care · doi:10.1186/s13054-021-03460-5 · Cited by 310 · see citing works
Filbin, M. R., Mehta, A., Schneider, A. M., Kays, K. R., Guess, J. R., Gentili, M., Fenyves, B. G., Charland, N. C., Gonye, A. L. K., Gushterova, I., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100287 · Cited by 296 · see citing works
Xiao, N., Nie, M., Pang, H., Wang, B.-H., Hu, J.-L., Meng, X., Li, K., Ran, X.-R., Long, Q.-X., Deng, H.-J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21907-9 · Cited by 257 · see citing works
Interleukin-6: obstacles to targeting a complex cytokine in critical illness
McElvaney, O. J., Curley, G. F., Rose‐John, S., & McElvaney, N. G. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00103-x · Cited by 284 · see citing works
Trougakos, I., Stamatelopoulos, K., Terpos, E., Tsitsilonis, O., Aivalioti, E., Paraskevis, D., Kastritis, E., Pavlakis, G., & Dimopoulos, M. (2021) · Journal of Biomedical Sciences · doi:10.1186/s12929-020-00703-5 · Cited by 241 · see citing works
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
Ferreira, A. C., Soares, V. C., de Azevedo-Quintanilha, I. G., Dias, S. D. S. G., Rodrigues, N. F., Sacramento, C. Q., Mattos, M., de Freitas, C. S., Temerozo, J. R., Teixeira, L., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00428-w · Cited by 269 · see citing works
Ramaswamy, A., Brodsky, N. N., Sumida, T. S., Comi, M., Asashima, H., Hoehn, K. B., Li, N., Liu, Y., Shah, A. S., Ravindra, N. G., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.003 · Cited by 270 · see citing works
The interferon landscape along the respiratory tract impacts the severity of COVID-19
Sposito, B., Broggi, A., Pandolfi, L., Crotta, S., Clementi, N., Ferrarese, R., Sisti, S., Criscuolo, E., Spreafico, R., Long, J. M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.016 · Cited by 264 · see citing works
Mudd, P. A., Crawford, J. C., Turner, J. S., Souquette, A. H., Reynolds, D., Bender, D. E., Bosanquet, J. P., Anand, N. J., Striker, D. A., Martin, R. S., et al. (2020) · Science Advances · doi:10.1126/sciadv.abe3024 · Cited by 266 · see citing works
Monocytes and Macrophages in COVID-19
Knoll, R., Schultze, J. L., & Schulte-Schrepping, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.720109 · Cited by 269 · see citing works
Bermejo-Martín, J. F., González‐Rivera, M., Almansa, R., Micheloud, D., Tedim, A. P., Domínguez‐Gil, M., Resino, S., Martín-Fernández, M., Ryan, P., Pérez‐García, F., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03398-0 · Cited by 264 · see citing works
Host-directed immunotherapy of viral and bacterial infections: past, present and future
Wallis, R. S., O’Garra, A., Sher, A., & Wack, A. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00734-z · Cited by 266 · see citing works
Prospects for a safe COVID-19 vaccine
Haynes, B. F., Corey, L., Fernandes, P., Gilbert, P. B., Hotez, P. J., Rao, S., Santos, M. R., Schuitemaker, H., Watson, M., & Arvin, A. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abe0948 · Cited by 261 · see citing works
NULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing
Feng, W., Beer, J. C., Hao, Q., Ariyapala, I. S., Sahajan, A., Komarov, A. M., Cha, K., Moua, M., Qiu, X., Xu, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42834-x · Cited by 257 · see citing works
Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19
Mann, E. R., Menon, M., Knight, S., Konkel, J. E., Jagger, C. P., Shaw, T. N., Krishnan, S., Rattray, M., Ustianowski, A., Bakerly, N. D., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd6197 · Cited by 242 · see citing works
Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome
Chen, L. Y. C., Hoiland, R. L., Stukas, S. K., Wellington, C. L., & Sekhon, M. S. (2020) · European Respiratory Journal · doi:10.1183/13993003.03006-2020 · Cited by 240 · see citing works
Thwaites, R. S., Uruchurtu, A. S. S., Siggins, M. K., Liew, F., Russell, C. D., Moore, S. C., Fairfield, C. J., Carter, E., Abrams, S. T., Short, C.-E. S., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abg9873 · Cited by 227 · see citing works
BNT162b2 vaccination induces durable SARS-CoV-2–specific T cells with a stem cell memory phenotype
Guerrera, G., Picozza, M., D’Orso, S., Placido, R., Pirronello, M., Verdiani, A., Termine, A., Fabrizio, C., Giannessi, F., Sambucci, M., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abl5344 · Cited by 222 · see citing works
Kusnadi, A., Ramírez-Suástegui, C., Fajardo, V., Chee, S., Meckiff, B. J., Simon, H. A., Pelosi, E., Seumois, G., Ay, F., Vijayanand, P., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abe4782 · Cited by 232 · see citing works
Vella, L. A., Giles, J. R., Baxter, A. E., Oldridge, D. A., Diorio, C. J., Kuri-Cervantes, L., Alanio, C., Pampena, M. B., Wu, J. E., Chen, Z., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abf7570 · Cited by 219 · see citing works
SARS‐CoV‐2 sensing by RIG‐I and MDA5 links epithelial infection to macrophage inflammation
Thorne, L., Reuschl, A., Zuliani‐Alvarez, L., Whelan, M. V. X., Turner, J. L. E., Noursadeghi, M., Jolly, C. L., & Towers, G. J. (2021) · The EMBO Journal · doi:10.15252/embj.2021107826 · Cited by 211 · see citing works
Chalmers, J. D., Crichton, M. L., Goeminne, P., Cao, B., Humbert, M. J. C., Shteinberg, M., Antoniou, K. M., Ulrik, C. S., Parks, H., Wang, C., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.00048-2021 · Cited by 221 · see citing works
Writing Committee for the REMAP-CAP Investigators, Abdelhady, H., Abdelrazik, M., Abdi, Z., Abdo, D., Abdulle, A., Abel, L., Abouzeenni, S., Abrahamson, G., Abusamra, Y., et al. (2021) · JAMA · doi:10.1001/jama.2021.18178 · Cited by 212 · see citing works
Wilk, A. J., Lee, M. J., Wei, B., Parks, B. E., Pi, R., Martínez-Colón, G. J., Ranganath, T., Zhao, N. Q., Taylor, S., Becker, W. R., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20210582 · Cited by 208 · see citing works
Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19
Liu, C., Martins, A. J., Lau, W. W., Rachmaninoff, N., Chen, J., Imberti, L., Mostaghimi, D., Fink, D. L., Burbelo, P. D., Dobbs, K., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.018 · Cited by 209 · see citing works
Glynne, P. A., Tahmasebi, N., Gant, V. A., & Gupta, R. (2021) · Journal of Investigative Medicine · doi:10.1136/jim-2021-002051 · Cited by 215 · see citing works
Hoang, T. N., Pino, M., Boddapati, A. K., Viox, E. G., Starke, C. E., Upadhyay, A. A., Gumber, S., Nekorchuk, M., Busman-Sahay, K., Strongin, Z., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.007 · Cited by 212 · see citing works
A time-resolved proteomic and prognostic map of COVID-19
Demichev, V., Tober-Lau, P., Lemke, O., Nazarenko, T., Thibeault, C., Whitwell, H., Röhl, A., Freiwald, A., Szyrwiel, L., Ludwig, D., et al. (2021) · Cell Systems · doi:10.1016/j.cels.2021.05.005 · Cited by 200 · see citing works
Activation or exhaustion of CD8+ T cells in patients with COVID-19
Rha, M., & Shin, E. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00750-4 · Cited by 193 · see citing works
Vijayakumar, B., Boustani, K., Ogger, P. P., Papadaki, A., Tonkin, J., Orton, C. M., Ghai, P., Suveizdytė, K., Hewitt, R. J., Desai, S. R., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.01.017 · Cited by 190 · see citing works
Profound Treg perturbations correlate with COVID-19 severity
Galván-Peña, S., Léon, J., Chowdhary, K., Michelson, D. A., Vijaykumar, B., Yang, L., Magnuson, A. M., Chen, F., Manickas-Hill, Z., Trocha, A. K., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111315118 · Cited by 185 · see citing works
Innate immunological pathways in COVID-19 pathogenesis
Paludan, S. R., & Mogensen, T. H. (2022) · Science Immunology · doi:10.1126/sciimmunol.abm5505 · Cited by 186 · see citing works
Thieme, C. J., Anft, M., Paniskaki, K., Blazquez-Navarro, A., Doevelaar, A., Seibert, F. S., Hoelzer, B., Konik, M. J., Berger, M. M., Brenner, T., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100092 · Cited by 184 · see citing works
Riou, C., Bruyn, E. D., Stek, C. J., Daroowala, R., Goliath, R. T., Abrahams, F., Said-Hartley, Q., Allwood, B., Hsiao, M., Wilkinson, K. A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci149125 · Cited by 204 · see citing works
Sun, Z., Song, Z., Liu, C., Tan, S., Lin, S., Zhu, J., Dai, F., Gao, J., She, J.-L., Mei, Z., et al. (2022) · BMC Medicine · doi:10.1186/s12916-021-02212-0 · Cited by 172 · see citing works
Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers
Danlos, F., Grajeda‐Iglesias, C., Durand, S., Sauvat, A., Roumier, M., Cantin, D., Colomba, É., Rohmer, J., Pommeret, F., Baciarello, G., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03540-y · Cited by 168 · see citing works
The known unknowns of T cell immunity to COVID-19
Karlsson, A. C., Humbert, M., & Buggert, M. (2020) · Science Immunology · doi:10.1126/sciimmunol.abe8063 · Cited by 165 · see citing works
Gyöngyösi, M., Alcaide, P., Asselbergs, F. W., Brundel, B. J. J. M., Camici, G. G., Martins, P. A. D. C., Ferdinandy, P., Fontana, M., Girão, H., Gnecchi, M., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac115 · Cited by 167 · see citing works
Livanos, A. E., Jha, D., Cossarini, F., Gonzalez-Reiche, A. S., Tokuyama, M. A., Aydillo, T., Parigi, T. L., Ladinsky, M. S., Ramos, I., Dunleavy, K. A., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.02.056 · Cited by 161 · see citing works
Gutmann, C., Takov, K., Burnap, S. A., Singh, B., Ali, H., Theofilatos, K., Reed, E., Hasman, M., Nabeebaccus, A., Fish, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23494-1 · Cited by 159 · see citing works
Self-citationLévy, Y., Wiedemann, A., Hejblum, B. P., Durand, M., Lefebvre, C., Surénaud, M., Lacabaratz, C., Perreau, M., Foucat, E., Déchenaud, M., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102711 · Cited by 161 · see citing works
COVID-19 therapeutics: Challenges and directions for the future
Robinson, P. C., Liew, D. F. L., Tanner, H. L., Grainger, J. R., Dwek, R. A., Reisler, R. B., Steinman, L., Feldmann, M., Ho, L., Hussell, T., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119893119 · Cited by 156 · see citing works
Alterations in T and B cell function persist in convalescent COVID-19 patients
Shuwa, H. A., Shaw, T. N., Knight, S., Wemyss, K., McClure, F. A., Pearmain, L., Prise, I. E., Jagger, C. P., Morgan, D. J., Khan, S., et al. (2020) · Med · doi:10.1016/j.medj.2021.03.013 · Cited by 170 · see citing works
SARS-CoV-2-specific T cells in infection and vaccination
Bertoletti, A., Le Bert, N., Qui, M., & Tan, A. T. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00743-3 · Cited by 159 · see citing works
Zheng, J. H., Wang, Y., Li, K., Meyerholz, D. K., Allamargot, C., & Perlman, S. M. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa753 · Cited by 158 · see citing works
Saichi, M., Ladjemi, M. Z., Korniotis, S., Rousseau, C., Hamou, Z. A., Massenet-Regad, L., Amblard, E., Noël, F., Marie, Y., Bouteiller, D., et al. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00681-2 · Cited by 151 · see citing works
Integrated immune dynamics define correlates of COVID-19 severity and antibody responses
Koutsakos, M., Rowntree, L. C., Hensen, L., Chua, B. Y. L., van de Sandt, C. E., Habel, J. R., Zhang, W., Jia, X., Kedzierski, Ł., Ashhurst, T. M., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100208 · Cited by 154 · see citing works
Bilich, T., Nelde, A., Heitmann, J. S., Maringer, Y., Roerden, M., Bauer, J., Rieth, J., Wacker, M., Peter, A., Hörber, S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf7517 · Cited by 147 · see citing works
Metabolic programs define dysfunctional immune responses in severe COVID-19 patients
Thompson, E. A., Cascino, K., Ordoñez, A. A., Zhou, W., Vaghasia, A. M., Hamacher‐Brady, A., Brady, N. R., Sun, I., Wang, R., Rosenberg, A. Z., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108863 · Cited by 152 · see citing works
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19
Brunetta, E., Folci, M., Bottazzi, B., Santis, M. D., Gritti, G., Protti, A., Mapelli, S. N., Bonovas, S., Piovani, D., Leone, R., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-00832-x · Cited by 153 · see citing works
Pathogenesis of Respiratory Viral and Fungal Coinfections
Salazar, F., Bignell, E., Brown, G. D., Cook, P. C., & Warris, A. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00094-21 · Cited by 155 · see citing works
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity
Rosa, A., Pye, V. E., Graham, C., Muir, L., Seow, J., Ng, K., Cook, N., Rees-Spear, C., Parker, E., dos Santos, M. S., et al. (2021) · SciAdv · doi:10.1126/sciadv.abg7607 · Cited by 120 · see citing works
Self-citationGraham, C., Seow, J., Huettner, I., Khan, H., Kouphou, N., Acors, S., Winstone, H., Pickering, S., Galão, R. P., Dupont, L., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.03.023 · Cited by 130 · see citing works
Self-citationAdaptive Immune Responses and Immunity to SARS-CoV-2
Primorac, D., Vrdoljak, K., Brlek, P., Pavelić, E., Molnar, V., Matišić, V., Ivkošić, I. E., & Parčina, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.848582 · Cited by 151 · see citing works
Deciphering the state of immune silence in fatal COVID-19 patients
Bost, P., Sanctis, F. D., Canè, S., Ugel, S., Donadello, K., Castellucci, M., David, E., Fiore, A., Anselmi, C., Barouni, R. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21702-6 · Cited by 144 · see citing works
Coperchini, F., Chiovato, L., Ricci, G., Croce, L., Magri, F., & Rotondi, M. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.12.005 · Cited by 133 · see citing works
Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients
Hellmuth, J. M., Barnett, T. A., Asken, B. M., Kelly, J. D., Torres, L., Stephens, M. L., Greenhouse, B., Martin, J. N., Chow, F. C., Deeks, S. G., et al. (2021) · Journal of NeuroVirology · doi:10.1007/s13365-021-00954-4 · Cited by 175 · see citing works
Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19
Kappelmann, N., Dantzer, R., & Khandaker, G. M. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105295 · Cited by 138 · see citing works
Reappearance of effector T cells is associated with recovery from COVID-19
Odak, I., Barros‐Martins, J., Bošnjak, B., Stahl, K., David, S., Wiesner, O., Busch, M., Hoeper, M. M., Pink, I., Welte, T., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102885 · Cited by 134 · see citing works
Peluso, M. J., Kelly, J. D., Lu, S., Goldberg, S. A., Davidson, M. C., Mathur, S., Durstenfeld, M. S., Spinelli, M. A., Hoh, R., Tai, V., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab640 · Cited by 126 · see citing works
T cell immunobiology and cytokine storm of COVID‐19
Luo, X.-H., Zhu, Y., Mao, J., & Du, R. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12989 · Cited by 106 · see citing works
Zeng, J., Xie, X., Feng, X., Xu, L., Han, J.-B., Yu, D., Zou, Q., Liu, Q., Li, X., Ma, G., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103803 · Cited by 128 · see citing works
Immunological memory to SARS-CoV-2 assessed for up to eight months after infectionPreprint
Dan, J., Mateus, J., Kato, Y., Hastie, K., Yu, E., Faliti, C. E., Grifoni, A., Ramirez, S., Haupt, S., Frazier, A., et al. (2020) · bioRxiv · doi:10.1101/2020.11.15.383323 · Cited by 147 · see citing works
- Authors
- Laing, A. G., Lorenc, A., del Molino del Barrio, I., Das, A., Fish, M., Monin, L., Muñoz-Ruiz, M., McKenzie, D. R., Hayday, T. S., Francos-Quijorna, I., Kamdar, S., Joseph, M., Davies, D., Davis, R., Jennings, A., Zlatareva, I., Vantourout, P., Wu, Y., Sofra, V., Cano, F., Greco, M., Theodoridis, E., Freedman, J. D., Gee, S., Chan, J. N. E., Ryan, S., Bugallo-Blanco, E., Peterson, P., Kisand, K., Haljasmägi, L., Chadli, L., Moingeon, P., Martinez, L., Merrick, B., Bisnauthsing, K., Brooks, K., Ibrahim, M. A. A., Mason, J., Lopez Gomez, F., Babalola, K., Abdul-Jawad, S., Cason, J., Mant, C., Seow, J., Graham, C., Doores, K. J., Di Rosa, F., Edgeworth, J., Shankar-Hari, M., & Hayday, A. C.
- Affiliations
- King's College London (GB)
- Guy's Hospital (GB)
- The Francis Crick Institute (GB)
- Royal Free London NHS Foundation Trust (GB)
- University of Tartu (EE)
- Servier (France) (FR)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- King's College Hospital NHS Foundation Trust (GB)
- European Bioinformatics Institute (GB)
- Corresponding author
- Hayday, Adrian C.
- ORCID
- Laing, Adam G.
- Lorenc, Anna
- Das, Abhishek
- Fish, Matthew
- Monin, Leticia
- McKenzie, Duncan R.
- Hayday, Thomas S.
- Francos-Quijorna, Isaac
- Kamdar, Shraddha
- Joseph, Magdalene
- Davies, Daniel
- Davis, Richard
- Jennings, Aislinn
- Zlatareva, Iva
- Vantourout, Pierre
- Wu, Yin
- Cano, Florencia
- Greco, Maria
- Freedman, Joshua D.
- Gee, Sarah
- Chan, Julie Nuo En
- Ryan, Sarah
- Bugallo-Blanco, Eva
- Peterson, Pärt
- Kisand, Kai
- Haljasmägi, Liis
- Chadli, Loubna
- Moingeon, Philippe
- Martinez, Lauren
- Merrick, Blair
- Bisnauthsing, Karen
- Brooks, Kate
- Ibrahim, Mohammad A. A.
- Mason, Jeremy
- Lopez Gomez, Federico
- Babalola, Kola
- Abdul-Jawad, Sultan
- Mant, Christine
- Seow, Jeffrey
- Doores, Katie J.
- Edgeworth, Jonathan
- Shankar-Hari, Manu
- Hayday, Adrian C.
- Venue
- Nature Medicine
- Published
- 2020-08-17
- Volume
- 26
- Issue
- 10
- Pages
- 1623-1635
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W3049325061
- Cited by
- 946
- References
- 94
- Citations by year
- 2026: 24 · 2025: 50 · 2024: 110 · 2023: 123 · 2022: 216 · 2021: 322 · 2020: 97 · 2014: 2
- FWCI
- 25.06
- Type
- journal article
- Language
- en
- Update notices
- Open access
- bronze
- doi.org
- Locations
- Nature Medicine (publishedVersion)
- medRxiv (acceptedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (106292/Z/4/Z)
- National Institute for Academic Anaesthesia (WKR0-2018-0047)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
- Keywords
- COVID-19 pandemic, SARS-CoV-2, immune signatures, peripheral immune cells, B cells, myelomonocytic cells, T cell phenotype, cytokines and chemokines, SARS-CoV-2 antibodies, plasmacytoid dendritic cells, disease severity, prognostic factors, CXCL10, IL-10, interleukin-6, patient stratification
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Aged, Antibodies, Viral, B-Lymphocytes, Basophils, Cell Cycle, Dendritic Cells, Female, Flow Cytometry, Hospitalization, Humans, Immunologic Memory, Leukocyte Count, Lymphocyte Activation, Male, Middle Aged, Pneumonia, Viral, Prognosis, Severity of Illness Index, T-Lymphocytes, Cohort Studies, Interleukin-6, Up-Regulation, Case-Control Studies, Immunophenotyping, B-Lymphocyte Subsets, T-Lymphocyte Subsets, Cytokines, Interleukin-10, Coronavirus Infections, Disease Progression, Chemokines, Chemokine CXCL10, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
